Showing results (401-410 of 437) with videos related to

Sort By:
Pageof 44
Journal of General Internal Medicine|March 11, 2021
Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO RegistryChristopher B Forrest, Haolin Xu, Laine E Thomas, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
NPJ Precision Oncology|July 24, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilitiesEunice S Li, Rebecca Ho, Ran Tao, et al.
Nature Communications|November 22, 2023
Enhancing the sensitivity of atom-interferometric inertial sensors using robust controlJack C Saywell, Max S Carey, Philip S Light, et al.
Pharmacoepidemiology and Drug Safety|April 23, 2025
Impact of State Policies on Opioid Prescribing Among Surgery and Injury Patients: Controlled Interrupted Time-Series Study, North Carolina, 2014-2019Theo G Beltran, Brian W Pence, Naoko Fulcher, et al.
United European Gastroenterology Journal|November 5, 2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibA G Duffy, S V Ulahannan, L Cao, et al.
The Astrophysical Journal|August 29, 2020
Variability Timescale and Spectral Index of Sgr A* in the Near Infrared: Approximate Bayesian Computation Analysis of the Variability of the Closest Supermassive Black HoleG Witzel, G Martinez, J Hora, et al.
Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.
Gynecologic Oncology|April 6, 2024
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinomaRobert L Hollis, Richard Elliott, John C Dawson, et al.
The Journal of Pathology|March 8, 2011
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomasMelissa K McConechy, Michael S Anglesio, Steve E Kalloger, et al.
Pageof 44